[A Case of Granulocyte-Colony Stimulating Factor-Producing Gastric Cancer Successfully Treated with Trastuzumab]

Gan To Kagaku Ryoho. 2015 Nov;42(12):1968-70.
[Article in Japanese]

Abstract

A 68-year-old man diagnosed with type 0-Ⅰgastric cancer by gastrointestinal endoscopy underwent urgent distal gastrectomy due to a perforation during endoscopic submucosal resection. Pathological examination revealed pT3N2M0, pStage ⅢA. TS-1 was administered as adjuvant chemotherapy. Laboratory examinations 10 months after surgery revealed leukocytosis (19,100/mL). Positron emission tomography-CT demonstrated metastases in the bone marrow and ascending colon as well as around the liver. Chemotherapy using nab-PTX had poor efficacy and the leukocytosis worsened. Serum granulocyte- colony stimulating facto (r G-CSF) was high at 1,640 pg/mL, and immunohistochemical staining was positive for G-CSF. Thus, the patient was diagnosed with G-CSF-producing gastric cancer. The tumor was also positive for HER2 antibody by immunohistochemical staining. Combination therapy using TS-1 plus CDDP plus trastuzumab resulted in a good response, and the leukocytosis and elevated serum G-CSF gradually improved. The patient is living 30 months postoperatively and remains on chemotherapy.

Publication types

  • Case Reports
  • English Abstract
  • Review

MeSH terms

  • Aged
  • Gastrectomy
  • Granulocyte Colony-Stimulating Factor / biosynthesis*
  • Humans
  • Male
  • Multimodal Imaging
  • Positron-Emission Tomography
  • Prognosis
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery
  • Tomography, X-Ray Computed
  • Trastuzumab / therapeutic use*

Substances

  • Granulocyte Colony-Stimulating Factor
  • Trastuzumab